ARTICLE | Company News
Claragen, National Institutes of Health deal
June 9, 1997 7:00 AM UTC
ClaraGen received an exclusive license to results of NIH research on the protein uteroglobin (also known as CC10), which include preclinical experiments relevant to treatment of neonatal bronchopulmon...